IL1B and chronic kidney disease: Increasing studies have proposed that excessive endogenous and exogenous mediators could induce sterile inflammation in CKD, releasing a variety of pro-inflammatory cytokines (e.g. IL-6, IL-1β and IL-18) which have been implicated in the progression of CKD and development of subsequent cardiovascular diseases [10].